铜依赖性细胞死亡及铜在乳腺癌治疗中的研究现状

doi:10.11904/j.issn.1002-3070.2023.02.017

摘要/Abstract

摘要： 目的铜是一种参与多种生物过程的金属元素,维持铜离子平衡是保持机体健康的重要条件,铜与多种疾病的发生发展相关,其中包括恶性肿瘤。“铜死亡”是最新提出的一种依赖于细胞内铜积累的新型细胞死亡方式。研究表明,铜的动态平衡与乳腺癌的发生发展有关,铜在乳腺癌治疗中的研究也日益兴起,本文主要就铜依赖性细胞死亡的发生机制及铜在乳腺癌治疗中的研究现状作一综述。

关键词: 铜, 铜死亡, 铜离子载体, 乳腺癌治疗

Abstract: Copper is a metal element involved in a variety of biological processes.Maintaining the balance of copper ions is an important condition for maintaining the health of body.Copper is related to the occurrence and development of many diseases,including malignant tumors."Cuprotosis" is a newly proposed cell death mode that depends on the accumulation of intracellular copper.Studies have shown that the dynamic balance of copper is related to the occurrence and development of breast cancer,and the research on copper in the treatment of breast cancer is also rising.This article mainly summarizes the mechanism of copper-dependent cell death and the research status of copper in breast cancer.

Key words: Copper, Cuprotosis, Copperion carrier, Breast cancer treatment

中图分类号:

R737.9

文世超, 王静萱. 铜依赖性细胞死亡及铜在乳腺癌治疗中的研究现状[J]. 实用肿瘤学杂志, 2023, 37(2): 185-189.

WEN Shichao, WANG Jingxuan. Research status of copper-dependent cell death and copper in breast cancer[J]. Journal of Practical Oncology, 2023, 37(2): 185-189.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2023.02.017

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2023/V37/I2/185

参考文献

1 Guo H,Wang Y,Cui H,et al.Copper induces spleen damage through modulation of oxidative stress,apoptosis,DNA damage,and inflammation[J].Biol Trace Elem Res,2022,200(2):669-677.
2 Zischka H,Einer C.Mitochondrial copper homeostasis and its derailment in Wilson disease[J].Int J Biochem Cell Biol,2018,102:71-75.
3 Tsvetkov P,Coy S,Petrova B,et al.Copper induces cell death by targeting lipoylated TCA cycle proteins[J].Science,2022,375(6586):1254-1261.
4 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
5 Cao B,Lei YT,Xue H,et al.Changes in the serum concentrations of essential trace metals in patients with benign and malignant breast cancers[J].Biol Trace Elem Res,2022,200(8):3537-3544.
6 Festa RA,Thiele DJ.Copper:an essential metal in biology[J].Curr Biol,2011,21(21):R877-883.
7 Lin C,Zhang Z,Wang T,et al.Copper uptake by DMT1:a compensatory mechanism for CTR1 deficiency in human umbilical vein endothelial cells[J].Metallomics,2015,7(8):1285-1289.
8 Chen J,Jiang Y,Shi H,et al.The molecular mechanisms of copper metabolism and its roles in human diseases[J].Pflugers Arch,2020,472(10):1415-1429.
9 Lee JY,Kim YH,Kim TW,et al.New novel mutation of the ATP7B gene in a family with Wilson disease[J].J Neurol Sci,2012,313(1-2):129-131.
10 Jiang X,Stockwell BR,Conrad M.Ferroptosis:mechanisms,biology and role in disease[J].Nat Rev Mol Cell Biol,2021,22(4):266-282.
11 Zheng P,Zhou C,Lu L,et al.Elesclomol:a copper ionophore targeting mitochondrial metabolism for cancer therapy[J].J Exp Clin Cancer Res,2022,41(1):271.
12 Nagai M,Vo NH,Shin Ogawa L,et al.The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells[J].Free Radic Biol Med,2012,52(10):2142-2150.
13 Yang L,Zhang Y,Wang Y,et al.Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity:a pan-cancer analysis[J].Front Pharmacol,2022,13:938134.
14 Tsvetkov P,Detappe A,Cai K,et al.Mitochondrial metabolism promotes adaptation to proteotoxic stress published correction appears in Nat Chem Biol[J].Nat Chem Biol,2019,15(7):681-689.
15 Rowland EA,Snowden CK,Cristea IM.Protein lipoylation:an evolutionarily conserved metabolic regulator of health and disease[J].Curr Opin Chem Biol,2018,42:76-85.
16 Li X,Dai Z,Liu J,et al.Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer[J].Front Genet,2022,13:969856.
17 Sha S,Si L,Wu X,et al.Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer[J].Front Immunol,2022,13:922780.
18 Xu B,Hu X,Feng J,et al.Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer(2018)[J].Cancer,2020,126(S16):3867-3882.
19 Kamiya T.Copper in the tumor micro environment and tumor metastasis[J].J Clin Biochem Nutr,2022,71(1):22-28.
20 Baharvand M,Manifar S,Akkafan R,et al.Serum levels of ferritin,copper,and zinc in patients with oral cancer[J].Biomed J,2014,37(5):331-356.
21 Booth BA,Sartorelli AC.Synergistic interaction of kethoxal bis(thiosemicarbazone)and cupric ions in sarcoma 180[J].Nature,1966,210(5031):104-105.
22 Li Y.Copper homeostasis:Emerging target for cancer treatment[J].IUBMB Life,2020,72(9):1900-1908.
23 Goodman VL,Brewer GJ,Merajver SD.Control of copper status for cancer therapy[J].Current cancer drug targets,2005(7):543-549.
24 Liang ZD,Long Y,Tsai WB,et al.Mechanistic basis for overcoming platinum resistance using copper chelating agents[J].Mol Cancer Ther,2012,11(11):2483-2494.
25 Yip NC,Fombon IS,Liu P,et al.Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties[J].Br J Cancer,2011,104(10):1564-1574.
26 Allensworth JL,Evans MK,Bertucci F,et al.Disulfiram(DSF)acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer[J].Mol Oncol,2015,9(6):1155-1168.
27 McMahon A,Chen W,Li F.Old wine in new bottles:Advanced drug delivery systems for disulfiram-based cancer therapy[J].J Control Release,2020,319:352-359.
28 Han D,Wu G,Chang C,et al.Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway[J].Oncotarget,2015,6(38):40907-40919.
29 Feng Y,Zeng JW,Ma Q,et al.Serum copper and zinc levels in breast cancer:A meta-analysis[J].J Trace Elem Med Biol,2020,62:126629.
30 MacDonald G,Nalvarte I,Smirnova T,et al.Memo is a copper-dependent redox protein with an essential role in migration and metastasis[J].Sci Signal,2014,7(329):ra56.
31 Li L,Li L,Sun Q.High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer:an analysis based on public databases[J].BMC Bioinformatics,2022,23(1):1-15.
32 Blockhuys S,Wittung-Stafshede P.Copper chaperone Atox1 plays role in breast cancer cell migration[J].Biochem Biophys Res Commun,2017,483(1):301-304.
33 Ahn SG,Dong SM,Oshima A,et al.LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients[J].Breast Cancer Res Treat.2013;141(1):89-99.
34 Karginova O,Weekley CM,Raoul A,et al.Inhibition of copper transport induces apoptosis in triple-negative breast cancer cells and suppresses tumor angiogenesis[J].Mol Cancer Ther,2019,18(5):873-885.
35 Liu L,Yi J,Yuan J,et al.FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer[J].Cancer Biomark,2020,28(1):1-8.
36 Zeng R,Peng B,Peng E.Downregulated copper homeostasis-related gene FOXO1 as a novel indicator for the prognosis and immune response of breast cancer.[J].J Immunol Res,2022,2022:9140461.
37 Feng Q,Zhang Y,Zhang W,et al.Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography[J].Acta Biomaterialia,2016,38:129-142.
38 Shrestha S,Wu J,Sah B,et al.X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors[J].Proc Natl Acad Sci U S A.2019;116(34):16823-16828.
39 Zheng R,Cheng Y,et al.Biodegradable copper-based nanoparticles augmented chemodynamic therapy through deep penetration and suppressing antioxidant activity in tumors[J].Adv Healthc Mater,2021,10(14):e2100412.
40 Voli F,Valli E,Lerra L,et al.Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion[J].Cancer Res,2020,80(19):41.